Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Carlos Fernández de Larrea

51-100 of 125 results

Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?

scientific article published on January 10, 2014

At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study

scientific article published on 23 November 2015

Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature

scientific article

Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma

scientific article published on 25 February 2019

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

scientific article published on 19 October 2020

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis

scientific article published on 21 January 2019

Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis

scientific article published on 18 April 2017

Prothrombin index prolongation due to N-acetylcysteine during the treatment of Amanita phalloides poisoning

scientific article

How to Treat Multiple Myeloma: Thoughts on a Multicentre Survey in Germany

scientific article published on October 25, 2010

Transient palindromic rheumatism induced by chimeric antigen receptor T-cell therapy

scholarly article

Why Immunotherapy Fails in Multiple Myeloma

scientific article published on 22 December 2020

Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells

scientific article published on 3 February 2025

Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution

scientific article published on 16 September 2022

Future prospects of chimeric antigen receptor T‐cell therapy for multiple myeloma

scientific article published on 21 July 2019

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

scholarly article

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma

scientific article published on 01 September 2020

Síndrome de Schnitzler: descripción de 3 casos

scientific article published on 05 March 2016

Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma

scientific article published on 17 August 2021

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

scientific article

BET Bromodomain Blockade Enhances Ikaros Inhibition By Lenalidomide Therapy Providing Additional Activity in In Vitro and In Vivo Models of Multiple Myeloma

scholarly article

Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors

scientific article published in April 2025

Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

scientific article published on 19 July 2023

Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis

scientific article published on 01 January 2019

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever

scientific article published on 04 November 2020

Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

scientific article published on 29 May 2020

Pattern of Relapse and Progression After Autologous Stem-Cell Transplantation As Upfront Treatment for Multiple Myeloma

scholarly article

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

scholarly article

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

scientific article published on 08 June 2020

Single-Cell Multiomics Reveals Regulatory Mechanisms of CAR T Cell Persistence and Dysfunction in Multiple Myeloma

scientific article published on 6 April 2025

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

scientific article published on 2 November 2023

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

scholarly article

Oligoclonal Bands In Patients with Multiple Myeloma In Complete Remission After Induction Chemotherapy: Strong Association with the Use of Novel Agents

scholarly article

Plasma Circulating Proteasomes As Biomarkers Along Natural History Of Asymptomatic Monoclonal Gammopathies

scholarly article

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period

scientific article published on 7 October 2021

CAR T Cell Therapy Targeting G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D), a Novel Target for the Immunotherapy of Multiple Myeloma

scholarly article

Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P

scientific article published on 1 July 2025

Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CYCLO-LEN-DEX) for Previously Untreated Patients with Light-Chain Amyloidosis (AL)

scholarly article

Efficacy of Novel Agents on Soft-Tissue Plasmacytomas in Patients with Relapsed Multiple Myeloma

scholarly article

Allogeneic Stem-Sell Transplantation In Multiple Myeloma In Real Practice: Long-Term Results From a Single Institution

scholarly article

Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period

scientific article published on 26 May 2025

Observational retrospective study of the treatment of Waldenström’s macroglobulinemia with ibrutinib in routine clinical practice in Spain

scientific article published in July 2025

Impact of Single Nucleotide Polymorphisms in Genes Involved in miRNA Network on Survival and Progression After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma,

scholarly article

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

scientific article published on 28 July 2020

Natural History of Asymptomatic IgM Monoclonal Gammopathies: Impact of the Bone Marrow Aspiration into the Classification and Prognosis

scholarly article

Rheumatologic complications of CAR-T Cell therapy. Experience of a single center

scientific article published in April 2025

Cytoplasmic inclusions in leukocytes associated to cryoglobulinemia and IgG-kappa monoclonal gammapathy of undetermined significance

scientific article published on March 23, 2011

Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry

scholarly article

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy

scientific article published on 23 April 2021